erythrodysesthesia syndrome

e·ryth·ro·dys·es·the·si·a syn·drome

tingling sensation of the palms and soles, progressing to severe pain and tenderness with erythema and edema; caused by continuous infusion therapy.
References in periodicals archive ?
Adverse Reactions - The most commonly reported adverse drug reactions (25%) are diarrhea, stomatitis, palmar-plantar erythrodysesthesia syndrome (PPES), decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, hypertension, abdominal pain, and constipation.
20 April 2011 - Spanish biopharmaceutical company Advancell has announced the initiation of a clinical Phase IIb study of its treatment ATH008 for palmar-plantar erythrodysesthesia syndrome, or hand-foot syndrome, a painful side effect of chemotherapy.